Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Qian-Zhao Chen"'
Publikováno v:
Journal of Cellular Biochemistry. 118:1792-1802
Postmenopausal osteoporosis (PMOP)-related fractures usually result in morbidity and mortality in aging women, so it remains a global public health concern, and new effective safe treatments are urgently needed recently. Efficient osteogenesis from m
Autor:
Ke Wu, Bai-Cheng He, Lin-Yun Zhou, Rong-Xing Liu, Wen-Yan Ren, Yu-Hua Zeng, Ming Huang, Fang He, Wen-Juan Sun, Ying Shao, Yang Li, Qian-Zhao Chen, Xue-Lian Hu
Publikováno v:
International Journal of Oncology. 50:1011-1021
The diagnosis and treatment for colon cancer have been greatly developed, but the prognosis remains unsatisfactory. There is still a great clinical need to explore new efficacious drugs for colon cancer treatment. Tetrandrine (Tet) is a bis-benzyliso
Autor:
Bai-Cheng He, Qian-Zhao Chen, Lin-Yun Zhou, Rong-Xin Liu, Yu Yu, Zhong-Liang Deng, Wen-Juan Sun, Yu-Hua Zeng, Ying Shao, Jun-Qing Yang, Yang Li, Ke Wu, Wen-Yan Ren
Publikováno v:
International Journal of Molecular Medicine
Rosiglitazone (RSG) is a potent drug used in the treatment of insulin resistance; however, it is associated with marked skeletal toxicity. RSG-induced osteoporosis may contribute to the promotion of adipogenic differentiation at the expense of osteog
Autor:
Yu-Hua Zeng, Qiu-Xiang Wu, Ke Wu, Shuang-Xue Yuan, Bai-Cheng He, Wen-Juan Sun, Chun-Mei Ren, Yang Li, Ying Shao, Qian-Zhao Chen, Dong-Xu Wang, Jun-Qin Yang, Pu Zhang, Yu Yu, Yan Bai
Publikováno v:
Oncology Reports. 35:939-947
Colon cancer is one of the most common malignancies of the digestive system. Although more effective therapeutic strategies have been developed in the last decades, there is still a great clinical need to explore new treatment regimens for colon canc
Autor:
Zhen-Hua Chen, Wen-Juan Sun, Qiu-Xiang Wu, Ying Shao, Bai-Cheng He, Yu Yu, Yu-Hua Zeng, Ke Wu, Jun Huang, Qian-Zhao Chen, Yang Li, Dong-Xu Wang, Shuang‑Xue Yuan, Chun-Mei Ren
Publikováno v:
Oncology Reports. 34:3203-3211
Colon cancer is one of the most common malignancies. Although the current treatment regimes for colon cancer have been well-developed in the past decades, the prognosis remains still undesirable. It is still urgent to explore new treatment strategies
Autor:
Mao Nie, Qian-Zhao Chen, Zi-Jun Meng, Liangjun Yin, Ruidong Li, Bai-Cheng He, Zhong-Liang Deng, Nian Wu
Publikováno v:
International Journal of Oncology
Osteosarcoma (OS) is the most common malignant bone tumour and is considered to be a disease caused by a dysfunction in differentiation. Bone morphogenetic protein 9 (BMP9) is the most potent osteogenic factor in mesenchymal stem cells, but it cannot
Autor:
Wen-Yan Ren, Jia-Hui Zhu, Jin Wang, Yu-Hua Zeng, Qian-Zhao Chen, Ying Shao, Ming Huang, Bai-Cheng He, Lin-Yun Zhou, Yun-Peng Liao, Han Wang, Yang Li, Fang He, Ke Wu
Publikováno v:
Oncology reports. 38(1)
Colon cancer is common worldwide and accounts for the significant cancer related morbidity and mortality in patients. Although extensive advancement has been made in colon cancer treatment and diagnosis in the last decades, there is still a giant gap
Publikováno v:
Journal of cellular biochemistry. 118(7)
Postmenopausal osteoporosis (PMOP)-related fractures usually result in morbidity and mortality in aging women, so it remains a global public health concern, and new effective safe treatments are urgently needed recently. Efficient osteogenesis from m
Autor:
Qian‑Zhao Chen, Bai‑Cheng He, Yang Li, Yang Liu, Zhong‑Liang Deng, Wu Nian, Xiang Zou, Lin‑Yun Zhou, Dong‑Dong Tian, Ran‑Xi Zhang
Publikováno v:
International journal of oncology. 49(5)
Although multiple chemotherapeutic agents have been used for osteosarcoma (OS) treatment, their mechanisms need further study. Ursolic acid (UA), a pentacyclic triterpenoid, can reduce cell proliferation and induce apoptosis in various cancer cells,
Autor:
Ke Wu, Qiu-Xiang Wu, Ying Shao, Yu Yu, Qian-Zhao Chen, Yu-Hua Zeng, Bai-Cheng He, Yang Li, Jun-Qin Yang, Wen-Juan Sun, Chun-Mei Ren, Shuang-Xue Yuan
Publikováno v:
Oncology reports. 35(5)
Oridonin (ORI), a diterpenoid purified from Rabdosia rubescens, has been reported as a promising chemotherapy drug for colon cancer treatment; yet, the precise mechanisms underlying this anticancer activity remain unclear. In the present study, we in